Trial intelligence / Profile preview

Efficacy and Safety of YY-351 (Ginsam) in Type 2 Diabetes Mellitus

NCT01008163Phase 2Completed

Sponsor
Yuyu Pharma
Start
Jan 2008
Primary completion
Jun 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Ginsam in type 2 diabetes mellitus (T2DM), sponsored by Yuyu Pharma. Started Jan 2008; status: completed.

02

Drugs

Ginsam
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT01008163.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01008163.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call